Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Vistagen Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security | Fee | Amount (a) | Proposed | Maximum | Fee Rate | Amount of | Carry | Carry | Carry | Filing Fee Unsold | |||||||||||||||||||||
Newly Registered Securities | ||||||||||||||||||||||||||||||||
Fees to Be Paid | Equity | Common Stock | ||||||||||||||||||||||||||||||
Equity | Preferred Stock | |||||||||||||||||||||||||||||||
Other | Debt Securities | |||||||||||||||||||||||||||||||
Other | Warrants | |||||||||||||||||||||||||||||||
Other | Units | |||||||||||||||||||||||||||||||
Unallocated (Universal) | Rule 457(o) | (b) | (b) | $350,000,000(c) | 0.00014760 | $ | 51,660.00 | |||||||||||||||||||||||||
Fees Previously Paid | ||||||||||||||||||||||||||||||||
Carry Forward Securities | ||||||||||||||||||||||||||||||||
Carry Forward Securities | Unallocated (Universal) | Unallocated (Universal) | Rule 415(a)(6) | (d) | $ | 250,000,000 | 0.0001091 | $ | 27,275.00 | S-3 | 333-254299 | 03/26/2021 | $ | 11,803.07 | ||||||||||||||||||
Total Offering Amounts | $ | 51,660.00 | ||||||||||||||||||||||||||||||
Total Fees Previously Paid | $ | 11,803.07 | ||||||||||||||||||||||||||||||
Total Fee Offsets | - | |||||||||||||||||||||||||||||||
Net Fee Due | $ | 39,856.93 | ||||||||||||||||||||||||||||||
(a) | In accordance with Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transaction. |
(b) | Pursuant to Instruction 2.A.iii.b. of Item 16(b) of Form S-3, this information is not specified as to each class of securities to be registered. There is being registered hereby such indeterminate number of the securities of each identified class as may from time to time be issued at indeterminate prices. Securities registered hereunder may be sold separately, together or in units with other securities registered hereunder. |
(c) | The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act. |
(d) | On March 15, 2021, the Registrant filed a registration statement on Form S-3 (File No. 333-254299), or the Prior Registration Statement, to register securities with an aggregate maximum offering price of $250,000,000, and paid a registration fee of $27,257.00 in connection therewith. As of the date of this registration statement, an aggregate of $108,185,806.37 of securities registered on the Prior Registration Statement are unsold. Pursuant to Rule 415(a)(6), the Registrant is allowed to apply $11,803.07 toward the registration fee for this registration statement because the unsold securities are being moved from the Prior Registration Statement to this registration statement, and the registration fee previously paid by the Registrant relating to the unsold securities included on this registration statement will continue to be applied to such unsold securities. |
